RestorixHealth and Industry Leaders Highlight the Legacy, Innovation, and Healing Power of Hyperbaric Medicine In the evolving landscape of modern healthcare, few therapies demonstrate the blend of historical significance and…
Strategic partnership launches CIO Leadership Exchange to empower IT leaders with AI, data, and digital transformation expertise across community health centers nationwide The National Association of Community Health Centers (NACHC)…
BeOne Medicines Gains FDA Priority Review for TEVIMBRA in First-Line HER2+ Gastroesophageal Adenocarcinoma BeOne Medicines Ltd., a global oncology-focused biopharmaceutical company, has announced a major regulatory milestone in the development…
Strand Therapeutics Advances In Vivo CAR-T Therapy with Programmable circRNA Platform Strand Therapeutics, a clinical-stage biotechnology company at the forefront of programmable RNA medicines, has announced the presentation of compelling…
Motif Neurotech Secures FDA Approval for First Clinical Trial of Depression-Focused BCI Motif Neurotech, a pioneering brain-computer interface company focused on mental health innovation, has reached a major milestone with…
Fertility Specialists of Texas and First Fertility Highlight Expertise at ASPIRE 2026 Fertility Specialists of Texas and First Fertility, recognized leaders in advanced reproductive healthcare, are strengthening their position at…
DCA Plans Deal to Boost Growth and Finances Dental Care Alliance (DCA), one of the largest dental support organizations (DSOs) in the United States, has announced a significant strategic transaction…
Understanding the Hidden Risks of High Blood Pressure It is entirely possible to feel perfectly healthy and still be at serious risk. High blood pressure, medically known as hypertension, is…
Haemonetics’ VASCADE MVP® XL Demonstrates Strong Safety and Efficacy in Large-Bore Venous Closure, New Study Finds Haemonetics Corporation a global leader in medical technology solutions aimed at improving patient outcomes,…
Fulgent Genetics, Inc. Selected for Rapid Oral Presentation in Head & Neck Cancer Track at ASCO Annual Meeting 2026 Fulgent Genetics, Inc., a technology-driven company known for its established laboratory…
Federal Push Accelerates Psychedelic Therapies as Clinical Infrastructure Races to Keep Up The landscape of mental health treatment development is undergoing a significant transformation as recent federal action signals a…
CareDx Showcases 50+ Abstracts, 16 Oral Talks at ISHLT 2026 CareDx has announced its participation in the International Society for Heart and Lung Transplantation 46th Annual Meeting (ISHLT 2026), taking…